because there was no money, or because an agreemen

because there was no money, or because an agreement was made with an unreliable partner (the Chinese at the end of February), because there were no lenders / big Pharma willing to invest in us, because Moscato did not involve the old shareholders with a capital increase , because Barda & company did not pay a cent, because Ngio was not listed within the promised time frame (due to delays not only attributable to Gnbt), because Excellagen did not generate income as hoped, etc.